Sit Investment Associates’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-50,325
Closed -$8.47M 567
2018
Q1
$8.47M Sell
50,325
-44,550
-47% -$7.47M 0.21% 135
2017
Q4
$15.5M Sell
94,875
-20,880
-18% -$3.75M 0.37% 89
2017
Q3
$23.7M Sell
115,755
-9,680
-8% -$2.25M 0.59% 50
2017
Q2
$30.5M Buy
125,435
+103,110
+462% +$24.2M 0.75% 34
2017
Q1
$5.33M Sell
22,325
-1,025
-4% -$239K 0.13% 168
2016
Q4
$4.9M Sell
23,350
-9,572
-29% -$1.98M 0.13% 177
2016
Q3
$7.58M Sell
32,922
-3,208
-9% -$784K 0.2% 136
2016
Q2
$8.35M Sell
36,130
-1,100
-3% -$254K 0.22% 126
2016
Q1
$9.98M Sell
37,230
-500
-1% -$143K 0.18% 123
2015
Q4
$11.8M Sell
37,730
-3,297
-8% -$982K 0.22% 110
2015
Q3
$11.2M Sell
41,027
-3,636
-8% -$1.12M 0.21% 115
2015
Q2
$13.6M Sell
44,663
-1,742
-4% -$520K 0.25% 114
2015
Q1
$13.8M Buy
46,405
+5,400
+13% +$1.54M 0.24% 113
2014
Q4
$10.6M Sell
41,005
-1,350
-3% -$337K 0.18% 137
2014
Q3
$10.2M Buy
42,355
+175
+0.4% +$39.2K 0.18% 127
2014
Q2
$9.41M Buy
42,180
+12,005
+40% +$2.49M 0.16% 149
2014
Q1
$6.21M Buy
+30,175
New +$5.98M 0.11% 180

Other funds holding AGN

Sit Investment Associates's AGN Position: Q2 2018 in Review

Sit Investment Associates sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 50,325 shares — an estimated $8.47M sold.

Sit Investment Associates first reported a position in AGN in Q1 2014 and held it in 17 quarters. The position peaked at $30.5M in Q2 2017. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Sit Investment Associates reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Sit Investment Associates sold 50,325 Allergan plc shares in Q2 2018, an estimated $8.47M.
  • Sit Investment Associates first reported a position in Allergan plc in Q1 2014 and held it in 17 quarters.
  • Sit Investment Associates's Allergan plc position peaked at $30.5M in Q2 2017.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Sit Investment Associates's 13F filing for Q2 2018, filed 19 Jul 2018.